Allostery Investments LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $69.3 Billion distributed in 41 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Abivax Sa with a value of $6.87B, Centessa Pharmaceuticals PLC with a value of $5.5B, Kal Vista Pharmaceuticals, Inc. with a value of $5.29B, Merus N.V. with a value of $5.25B, and Evolus, Inc. with a value of $4.97B.

Examining the 13F form we can see an decrease of $26.4B in the current position value, from $95.7B to 69.3B.

Allostery Investments LP is based out at Stamford, CT

Below you can find more details about Allostery Investments LP portfolio as well as his latest detailed transactions.

Portfolio value $69.3 Billion
Healthcare: $52.1 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 41
  • Current Value $69.3 Billion
  • Prior Value $95.7 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 16 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Allostery Investments LP Portfolio

Follow Allostery Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allostery Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Allostery Investments LP with notifications on news.